Article (Scientific journals)
L'etude clinique du mois. Treating to New Targets": plaidoyer pour une valeur cible de cholesterol LDL egale ou inferieure a 75 mg/dl chez tout patient coronarien."
Scheen, André
2005In Revue Médicale de Liège, 60 (4), p. 264-7
Peer reviewed
 

Files


Full Text
200504_13.pdf
Publisher postprint (450.43 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Adult; Aged; Anticholesteremic Agents/therapeutic use; Cholesterol, LDL/blood; Coronary Disease/blood/drug therapy/etiology; Heptanoic Acids/therapeutic use; Humans; Hypercholesterolemia/complications/drug therapy; Middle Aged; Pyrroles/therapeutic use; Randomized Controlled Trials as Topic
Abstract :
[en] The "Treating to New Targets" (TNT) trial compared atorvastatin 80 mg (aiming at reducing LDL cholesterol < or = 75 mg/dl) and atorvastatin 10 mg (LDL < or = 100 mg/dl as target) in 10,001 patients with stable coronary heart disease followed up for 5 years. A reduction of major cardiovascular events of 22% was observed in the atorvastatin 80 mg group as compared to the atorvastatin 10 mg group (hazard ratio: 0.78; 95 % interval of confidence: 0.69-0.89; p < 0.001). Such clinical efficacy was obtained while a good drug safety profile was maintained. Total mortality was not significantly different between the two groups. However, and remarkably, cardiovascular death was not the first cause of death anymore in this atorvastatin-treated population. The results of TNT in patients with stable coronary heart disease thus confirm the results of PROVE-IT in patients with acute coronary syndrome. These two randomised controlled trials should encourage considering a LDL cholesterol level of 75 mg/dl (rather than 100 mg/dl) as a new target in any patient with coronary heart disease.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
French
Title :
L'etude clinique du mois. Treating to New Targets": plaidoyer pour une valeur cible de cholesterol LDL egale ou inferieure a 75 mg/dl chez tout patient coronarien."
Alternative titles :
[en] Treating to New Targets": plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease"
Publication date :
2005
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
60
Issue :
4
Pages :
264-7
Peer reviewed :
Peer reviewed
Additional URL :
Available on ORBi :
since 07 April 2009

Statistics


Number of views
250 (1 by ULiège)
Number of downloads
271 (3 by ULiège)

Scopus citations®
 
8
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi